原发性胆汁性肝硬化中B细胞免疫的研究进展

谭延国; 闫惠平; 高祖华

doi:10.3969/j.issn.1001-5256.2014.05.004

原发性胆汁性肝硬化中B细胞免疫的研究进展

DOI: 10.3969/j.issn.1001-5256.2014.05.004

1. 首都医科大学附属复兴医院检验科
2. 首都医科大学附属北京佑安医院感染与免疫研究中心
3. 首都医科大学附属北京佑安医院病理科

基金项目:

首都卫生发展专项基金(2011-2018-05)；

详细信息

中图分类号: R575.22
计量
- 文章访问数: 2743
- HTML全文浏览量: 18
- PDF下载量: 751
- 被引次数: 0
出版历程
- 出版日期: 2014-05-20

Research progress in role of B cell immunity in primary biliary cirrhosis

Research funding:

摘要

摘要:
原发性胆汁性肝硬化(PBC)以肝内小胆管的损伤为特征,但其损伤机制尤其是B细胞免疫在其中发挥的作用尚不明确。从B细胞和浆细胞在PBC肝组织中的分布、B细胞清除、PBC血清中异常增高的IgM产生机制及其组织器官来源、线粒体抗体的产生机制以及在胆管损伤中的可能作用、PBC中特征性的自身抗体等方面,回顾了B细胞免疫在PBC发病机制中的可能作用。通过以上分析,认为B细胞免疫的确在PBC的发病机制中发挥了重要作用,但仍有很多关键的问题尚未得到阐明。
- 肝硬化,胆汁性 /
- 免疫,体液 /
- B淋巴细胞 /
- 综述
Abstract:
Primary biliary cirrhosis ( PBC) is characterized by injury of small intrahepatic bile ducts, but its mechanism, especially the role of B cell immunity in this disease, remains unclear. The possible role of B cell immunity in the pathogenesis of PBC is reviewed from the following aspects: distribution of B cells and plasma cells in the liver tissues of PBC patients, clearance of B cells, mechanism of abnormal increase in serum IgM and its sources among PBC patients, mechanism of production of antimitochondrial antibodies and their possible functions in bile duct injury, and typical autoantibodies in PBC. B cell immunity is considered to play a significant role in the pathogenesis of PBC, but there are still many key problems to be clarified.
- liver cirrhosis, biliary /
- immunity, humoral /
- B lymphocytes /
- review

HTML全文

参考文献(33)

[1]BOGDANOS DP, KOMOROWSKI L.Disease-specific autoantibodies in primary biliary cirrhosis[J].Clin Chim Acta, 2011, 412 (7-8) :502-512.

[2]HIRSCHFIELD GM, GERSHWIN ME.Primary biliary cirrhosis:one disease with many faces[J].IMAJ, 2011, 13 (1) :55-59.

[3]YIN YF, ZHANG X.B cell depletion in treating primary biliary cirrhosis:pros and cons[J].World J Gastroenterol, 2012, 18 (30) :3938-3940.

[4]HU CJ, ZHANG FC, LI YZ, et al.Primary biliary cirrhosis:what do autoantibodies tell us?[J].World J Gastroenterol, 2010, 16 (29) :3616-3629.

[5]TAKAHASHI T, MIURA T, NAKAMURA J, et al.Plasma cells and the chronic nonsuppurative destructive cholangitis of primary billiary cirrhosis[J].Hepatology, 2012, 55 (3) :846-855.

[6]YOU Z, WANG Q, BIAN Z, et al.The immunopathology of liver granulomas in primary biliary cirrhosis[J].J Autoimmun, 2012, 39 (3) :216-221.

[7]RUBIO CA, TRUSKAITE K, RAJANI R, et al.A method to assess the distribution and frequency of plasma cells and plasma cell precursors inautoimmune hepatitis[J].Anticancer Res, 2013, 33 (2) :665-669.

[8]GMEZ-PUERTA JA, QUINTANA LF, STONE JH, et al.B-cell depleting agents for ANCA vasculitides:A new therapeutic approach[J].Autoimmun Rev, 2012, 11 (9) :646-652.

[9]AGARWAL SK.Biologic agents in rheumatoid arthritis:an update for managed care professionals[J].J Manag Care Pharm, 2011, 17:s14.

[10]DHIRAPONG A, LLEO A, YANG GX, et al.B cell depletion therapy exacerbates murine primary biliary cirrhosis[J].Hepatology, 2011, 53 (2) :527-535.

[11]MORITOKI Y, LIAN ZX, LINDOR K, et al.B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice[J].Hepatology, 2009, 50 (6) :1893-1903.

[12] TSUDA M, MORITOKI Y, LIAN ZX, et al.Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid[J].Hepatology, 2012, 55 (2) :512-521.

[13]MENNDEZ-CARO JL, ALVAREZ-MON M, GIRN JA, et al.Increased IgM B cell differentiation lymphokine production by T lymphocytes from patients with primary biliary cirrhosis[J].J Hepatol, 1994, 20 (4) :446-453.

[14] LLEO A, LIAO J, INVERNIZZI P, et al.Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis[J].Hepatology, 2012, 55 (1) :153-160.

[15]KIKUCHI K, LIAN ZX, KIMURA Y, et al.Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis[J].J Autoimmun, 2005, 24 (4) :347-352.

[16]KIKUCHI K, LIAN ZX, YANG GX, et al.Bacterial CpG induces hyper-IgM production in CD27 (+) memory B cells in primary biliary cirrhosis[J].Gastroenterology, 2005, 128 (2) :304-312.

[17]UIBO R, KISAND K, YANG CY, et al.Primary biliary cirrhosis:a multi-faced interactive disease involving genetics, environment and the immune response[J].APMIS, 2012, 120 (11) :857-871.

[18]ARANBURU A, CECCARELLI S, GIORDA E, et al.TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells[J].J Immunol, 2010, 185 (12) :7293-7301.

[19]KUROSAKI T, AIBA Y, KOMETANI K, et al.Unique properties of memory B cells of different isotypes[J].Immunol Rev, 2010, 237 (1) :104-116.

[20]KIKUCHI K, TSUNEYAMA K, YAMADA H, et al.Splenic lymph follicles generate IgM producing B cells in primary biliary cirrhosis[J].Hepatol Res, 2013, doi: 10.1111/hepr.12231.

[21]MCNALLY RJ, JAMES PW, DUCKER S, et al.Seasonal variation in the patient diagnosis of primary biliary cirrhosis:further evidence for an environmental component to etiology[J].Hepatology, 2011, 54 (6) :2099-2103.

[22] DANIELS JA, TORBENSON M, ANDERS RA, et al.Immunostaining of plasma cells in primary biliary cirrhosis[J].Am J Clin Pathol, 2009, 131 (2) :243-249.

[23]LEE H, STAPP RT, ORMSBY AH, et al.The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J].Am J Clin Pathol, 2010, 133 (3) :430-437.

[24]BJRKLAND A, LF L, MENDEL-HARTVIG I, et al.Primary biliary cirrhosis.High proportions of B cells in blood and liver tissue produce anti-mitochondrialantibodies of several Ig classes[J].J Immunol, 1994, 153 (6) :2750-2757.

[25]DHNRICH C, PARES A, CABALLERIA L, et al.New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies[J].Clin Chem, 2009, 55 (5) :978-985.

[26]AMBROSINI YM, YANG GX, ZHANG W, et al.The multi-hit hypothesis of primary biliary cirrhosis:polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis[J].Clin Exp Immunol, 2011, 166 (1) :110-120.

[27]LEUNG PS, PARK O, TSUNEYAMA K, et al.Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization[J].J Immunol, 2007, 179 (4) :2651-2657.

[28]HIRSCHFIELD GM, GERSHWIN ME.The immunobiology and pathophysiology of primary biliary cirrhosis[J].Annu Rev Pathol, 2013, 8:303-330.

[29]BERG PA.The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis:a conceptual view[J].Liver Int, 2011, 31 (7) :920-931.

[30]SFAKIANAKI O, TZARDI M, VOUMVOURAKI A, et al.Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis[J].World J Hepatol, 2013, 5 (10) :568-576.

[31]LLE A, BOWLUS CL, YANG GX, et al.Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis[J].Hepatology, 2010, 52 (3) :987-998.

[32]RONG G, ZHONG R, LLEO A, et al.Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis[J].Hepatology, 2011, 54 (1) :196-203.

[33]BHANJI RA, MASON AL, GIRGIS S, et al.Liver transplantationfor overlap syndromes of autoimmune liver diseases[J].Liver Int, 2013, 33 (2) :210-219.

施引文献

资源附件(0)

访问统计